Drug Trial Radar · NCT01358526
Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain
Last checked: Nov 20, 2026Latest source record: Nov 11, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,095
Actual
Start
May 2011
Primary completion
Oct 2012
Study completion Nov 2012
Sponsor
- Lead sponsor
- Purdue Pharma LPIndustry
- Sponsor type
- Industry
- First posted
- May 23, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to assess the efficacy and safety of OXN compared to placebo in opioid-experienced subjects with moderate to severe pain due to chronic low back pain who require around-the-clock opioid therapy.
Conditions
- Low Back Pain
Interventions
Oxycodone/Naloxone Controlled-releaseDrug
Oxycodone/Naloxone Controlled-release tablets (10/5 mg, 20/10 mg, 30/15 mg, 40/20 mg) taken orally every 12 hours
PlaceboDrug
Placebo tablets to match OXN taken orally every 12 hours
Primary outcomes
What the sponsor says the trial is designed to measure.
- The "Average Pain Over the Last 24 Hours" at Week 12 of the Double-blind PeriodTime frame: 24 hours (Week 12)
Locations
151 sites in 1 country. Site status is shown where the registry gives one.
Alabama Orthopaedic Center, PC
Birmingham, Alabama
Alliance Clinical Research
Birmingham, Alabama
Winston Technology Research, LLC
Haleyville, Alabama
Monte Sano Clinical Research, LLC
Huntsville, Alabama
Research Facility
Mobile, Alabama
Radiant Research, Inc.
Chandler, Arizona
Dedicated Clinical Research
Phoenix, Arizona
Arizona Research Center
Phoenix, Arizona
Clinical Research Advantage, Inc./Tatum Highlands Medical Associates, PLLC
Phoenix, Arizona
Quality of Life Medical & Research Center, LLC
Tucson, Arizona
Ortho Surgeons
Little Rock, Arkansas
Orange County Research Institute
Anaheim, California
Physician Alliance Research Center
Anaheim, California
Advanced Pain Research Institute
Arcadia, California
Southbay Pharma Research
Buena Park, California
Providence Clinical Research
Burbank, California
Med Center
Carmichael, California
Advanced Pain Management and Rehabilitation Medical Group, Inc.
Castro Valley, California
Catalina Research Institute, LLC
Chino, California
Synergy Clinical Research of Escondido
Escondido, California
Valley Research
Fresno, California
RX Clinical Research, Inc.
Garden Grove, California
TriWest Research Associates
La Mesa, California
Pacific Coast Pain Management Center
Laguna Hills, California
South Orange County Surgical Medical Group
Laguna Hills, California
Clinical Trials Research
Lincoln, California
L.A. Pain and Wellness Institute
Los Angeles, California
Newport Beach Clinical Research Associates, Inc.
Newport Beach, California
Lotus Clinical Research
Pasadena, California
Northern California Clinical Research Center
Redding, California
Probe Clinical Research Corporation
Riverside, California
Northern California Research
Sacramento, California
Probe Clinical Research Corporation
Santa Ana, California
Denver Internal Medicine Group
Denver, Colorado
Front Range Clinical Research
Wheat Ridge, Colorado
New England Research Associates, LLC
Trumbull, Connecticut
Orthopedic Research Institute
Boynton Beach, Florida
Coastal Orthopedics & Pain Management
Bradenton, Florida
Southeast Clinical Research, LLC
Chiefland, Florida
Innovative Research of West Florida, Inc.
Clearwater, Florida
Showing 40 of 151 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.